Doliver Advisors’s Aberdeen Intermediate Income Fund MIN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q3
Sell
-19,213
Closed -$74K 260
2018
Q2
$74K Sell
19,213
-19,104
-50% -$74K 0.03% 306
2018
Q1
$151K Buy
38,317
+9,624
+34% +$38.4K 0.07% 277
2017
Q4
$119K Sell
28,693
-4,315
-13% -$18.1K 0.05% 282
2017
Q3
$141K Sell
33,008
-89,215
-73% -$384K 0.06% 236
2017
Q2
$528K Sell
122,223
-3,953
-3% -$17.1K 0.26% 86
2017
Q1
$544K Buy
126,176
+49,527
+65% +$215K 0.43% 73
2016
Q4
$340K Buy
76,649
+17,019
+29% +$74.9K 0.29% 115
2016
Q3
$270K Buy
+59,630
New +$274K 0.23% 119
2015
Q3
Sell
-130,992
Closed -$605K 237
2015
Q2
$605K Buy
130,992
+110,110
+527% +$527K 0.4% 85
2015
Q1
$102K Sell
20,882
-83,044
-80% -$408K 0.07% 245
2014
Q4
$496K Buy
103,926
+47,811
+85% +$238K 0.35% 93
2014
Q3
$281K Buy
+56,115
New +$291K 0.19% 197
2013
Q4
Sell
-102,611
Closed -$545K 311
2013
Q3
$545K Sell
102,611
-174,819
-63% -$926K 0.33% 113
2013
Q2
$1.89M Buy
+277,430
New +$1.68M 1.11% 4

Other funds holding MIN

Doliver Advisors's MIN Position: Q3 2018 in Review

Doliver Advisors sold out of Aberdeen Intermediate Income Fund (MIN) in Q3 2018, closing a stake of 19,213 shares — an estimated $74K sold.

Doliver Advisors first reported a position in MIN in Q2 2013 and held it in 14 quarters. The position peaked at $1.89M in Q2 2013. 71 funds tracked by Wall St. Rank hold MIN as of Q3 2018.

  • Doliver Advisors reported no remaining Aberdeen Intermediate Income Fund position as of Q3 2018 after selling out during the quarter.
  • Doliver Advisors sold 19,213 Aberdeen Intermediate Income Fund shares in Q3 2018, an estimated $74K.
  • Doliver Advisors first reported a position in Aberdeen Intermediate Income Fund in Q2 2013 and held it in 14 quarters.
  • Doliver Advisors's Aberdeen Intermediate Income Fund position peaked at $1.89M in Q2 2013.
  • 71 funds tracked by Wall St. Rank held Aberdeen Intermediate Income Fund as of Q3 2018.

Based on Doliver Advisors's 13F filing for Q3 2018, filed 2 Nov 2018.